About Ceva
Ceva is a company based in Libourne (France) founded in 1999 was acquired by Natixis in April 2007. Ceva has raised $214.35 million across 11 funding rounds from investors including Mitsui & Co, Natixis and Tikehau Capital. Ceva has completed 10 acquisitions, including Aquilón Cyl, Artemis Wildlife Baits and Biotecnofe. Ceva operates in a competitive market with competitors including Zoetis, PetMedix, QBiotics, Bio-Sourcing and Hester Biosciences, among others.
- Headquarter Libourne, France
-
Sectors
HealthcareAgriculture
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$214.35 M (USD)
in 11 rounds
-
Latest Funding Round
$157.69 K (USD), Grant
Jun 10, 2022
-
Investors
Mitsui & Co.
& 17 more
-
Employee Count
Not available
-
Investments & Acquisitions
Aquilón Cyl
& 9 more
-
Acquired by
Natixis
(Apr 25, 2007)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Ceva
Unlock access to complete
Software Development Team
130 people
Sales and Marketing
41 people
Leadership Team
38 people
Finance and Accounting
31 people
Product Management Team
24 people
Global Team
10 people
Senior Team
9 people
Responsable Team
7 people
Unlock access to complete
Funding Insights of Ceva
Ceva has successfully raised a total of $214.35M across 11 strategic funding rounds. The most recent funding activity was a Grant round of $157.69 thousand completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Ceva
Ceva has secured backing from 18 investors, including institutional and venture fund investors. Prominent investors backing the company include Mitsui & Co, Natixis and Tikehau Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
An investment platform is provided for diverse sectors and geographies.
|
Locked | Locked | Locked | |
|
Private equity firm focused on energy, financial services, agriculture, and hospitality services
|
Locked | Locked | Locked | |
|
Pivate equity firm that focuses on investing in healthcare and nutrition companies
|
Locked | Locked | Locked |
Investor details for Ceva
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ceva
Ceva has strategically engaged in corporate development activities, having acquired 10 companies. Notable acquisitions include Aquilón Cyl, Artemis Wildlife Baits and Biotecnofe.
Investment portfolio details for Ceva
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Veterinary biotherapeutics research and development services are offered.
|
Locked | Locked | 2018 | Locked | |
|
Veterinary health products are supplied for animal care needs.
|
Locked | Locked | 2017 | Locked | |
|
Manufacturer of protein therapeutics for animal health
|
Locked | Locked | 2017 | Locked |
Complete acquisition details for Ceva
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Ceva
Detailed financials for Ceva
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ceva Comparisons
Peer comparison for Ceva
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ceva
Ceva operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zoetis, PetMedix, QBiotics, Bio-Sourcing and Hester Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Animal medicines, vaccines, and diagnostics are manufactured and supplied.
|
|
| Locked | Locked | Locked |
Developer of monoclonal antibody therapeutics for pets
|
|
| Locked | Locked | Locked |
Small molecules from plant extracts are developed for medical applications.
|
|
| Locked | Locked | Locked |
Biopharmaceuticals for animals are manufactured and supplied through partnerships.
|
|
| Locked | Locked | Locked |
Manufacturer of animal vaccines and healthcare products
|
Detailed competitors of Ceva
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ceva
Complete news archive for Ceva
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ceva
Ceva was founded in 1999 and raised its 1st funding round 11 years after it was founded.
Ceva is headquartered in Libourne, France. It is registered at Libourne, Nouvelle-aquitaine, France.
Marc Prikazsky is the current CEO of Ceva.
Ceva is a funded company, having raised a total of $214.35M across 11 funding rounds to date.
Ceva was founded in 1999 in Libourne, France, and operates in the animal health sector. Solutions for livestock such as cattle, poultry, sheep, and swine, as well as companion animals, are provided through pharmaceuticals and vaccines. The portfolio encompasses anti-infectives, anti-inflammatories, inactivated vaccines, intravaginal devices, and melatonin. Therapeutic options for conditions like behavioral disorders and renal failures in companion animals are also offered. Domestic and international markets are served.
Ceva has made 10 acquisitions, including Aquilón Cyl, Artemis Wildlife Baits, and Biotecnofe.
Ceva has 18 investors. Key investors include Mitsui & Co, Natixis, Tikehau Capital, Temasek, and Sagard.